Comprehensive Assay Portfolio: Beyond traditional chemiluminescence applications, it supports advanced diagnostics for specialized conditions such as stroke, Alzheimer's disease, thrombosis ...
The US Food and Drug Administration (FDA) has cleared Revvity’s automated chemiluminescence-based immunoassay (ChLIA) test for free testosterone. The authorisation by the agency marks the first ...
The ABBOTT PRISM System is an automated immunoassay analyzer designed to perform Chemiluminescent immunoassay (ChLIA) technology. The ABBOTT PRISM performs batch/continuous access and STAT ...
These chemiluminescent, no-wash assays are ideally ... advantageously with conventional enzyme-linked immunosorbent assay (ELISA). ELISA is the most widely used detection platform for the ...
Anbio Biotechnology ("Anbio"), a global leader in in-vitro diagnostic technologies, is excited to announce its participation ...
The ADVIA Centaur ® XPT Immunoassay System is engineered for ... testing with advanced acridinium ester technology—evolving chemiluminescence that provides the flexibility to meet changing ...
1d
Fapon, a global leading life sciences company, is showcasing its comprehensive one-stop IVD solutions and sharing the latest ...
The FDA cleared Euroimmun's automated chemiluminescence-based immunoassay test for free testosterone, said Revvity.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback